Automatic Diagnosis of Alzheimer’s Disease Using Deep Learning Techniques

2021 ◽  
Vol 19 (11) ◽  
pp. 126-140
Author(s):  
Zahraa S. Aaraji ◽  
Hawraa H. Abbas
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Deep Learning ◽  
Data Analysis ◽  
Binary Classification ◽  
Brain Mri ◽  
Three Dimensional ◽  
Structural Variations ◽  
Automatic Feature Extraction ◽  
Multi Class Classification

Neuroimaging data analysis has attracted a great deal of attention with respect to the accurate diagnosis of Alzheimer’s disease (AD). Magnetic Resonance Imaging (MRI) scanners have thus been commonly used to study AD-related brain structural variations, providing images that demonstrate both morphometric and anatomical changes in the human brain. Deep learning algorithms have already been effectively exploited in other medical image processing applications to identify features and recognise patterns for many diseases that affect the brain and other organs; this paper extends on this to describe a novel computer aided software pipeline for the classification and early diagnosis of AD. The proposed method uses two types of three-dimensional Convolutional Neural Networks (3D CNN) to facilitate brain MRI data analysis and automatic feature extraction and classification, so that pre-processing and post-processing are utilised to normalise the MRI data and facilitate pattern recognition. The experimental results show that the proposed approach achieves 97.5%, 82.5%, and 83.75% accuracy in terms of binary classification AD vs. cognitively normal (CN), CN vs. mild cognitive impairment (MCI) and MCI vs. AD, respectively, as well as 85% accuracy for multi class-classification, based on publicly available data sets from the Alzheimer’s disease Neuroimaging Initiative (ADNI).

scholarly journals Alzheimer’s Disease Classification using Leung-Malik Filtered Bank Features and Weak Classifier

2019 ◽  
Vol 8 (3) ◽  
pp. 1956-1961
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Filter Bank ◽  
Binary Classification ◽  
Brain Mri ◽  
Texture Features ◽  
Disease Classification ◽  
Weak Classifier ◽  
Frame Work ◽  
Multi Class Classification

We propose a frame work to classify Brain MRI images in to Alzheimer’s Disease (AD), Cognitive Normal (CN) and Mild Cognitive impairments (MCI). We use 114No’s of T2 weighted MRI Volumes. We extracted relative texture features from Leung-Malik Filter bank, k means is used to generate Bag of Dictionary (BoD) from LM Filtered images. We performed binary classification and Multi class Classification using different Classifiers, Adaboost Classifier gives better performance both in binary and multi class classifications in comparison with other classifiers. Performance of proposed system is enhanced than compared to the existing techniques. It has Sensitivity for AD-CN 89.8, AD-MCI 78.82, AD-CN-MCI 77.77, Specificity for AD-CN79.22, AD-MCI 80.00, AD-CN-MCI 58.88, and positive prediction value for AD-CN 79.48, AD-MCI 83.75, AD-CN-MCI 68.47 and Accuracy AD-CN 84.24, AD-MCI 79.33, AD-CN-MCI 72.88.

scholarly journals A multilayer multimodal detection and prediction model based on explainable artificial intelligence for Alzheimer’s disease

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Shaker El-Sappagh ◽  
Jose M. Alonso ◽  
S. M. Riazul Islam ◽  
Ahmad M. Sultan ◽  
Kyung Sup Kwak
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cross Validation ◽  
Disease Risk ◽  
Binary Classification ◽  
Fuzzy Rule ◽  
Large Set ◽  
Detection Model ◽  
Multi Class Classification ◽  
Clinical Measures

AbstractAlzheimer’s disease (AD) is the most common type of dementia. Its diagnosis and progression detection have been intensively studied. Nevertheless, research studies often have little effect on clinical practice mainly due to the following reasons: (1) Most studies depend mainly on a single modality, especially neuroimaging; (2) diagnosis and progression detection are usually studied separately as two independent problems; and (3) current studies concentrate mainly on optimizing the performance of complex machine learning models, while disregarding their explainability. As a result, physicians struggle to interpret these models, and feel it is hard to trust them. In this paper, we carefully develop an accurate and interpretable AD diagnosis and progression detection model. This model provides physicians with accurate decisions along with a set of explanations for every decision. Specifically, the model integrates 11 modalities of 1048 subjects from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) real-world dataset: 294 cognitively normal, 254 stable mild cognitive impairment (MCI), 232 progressive MCI, and 268 AD. It is actually a two-layer model with random forest (RF) as classifier algorithm. In the first layer, the model carries out a multi-class classification for the early diagnosis of AD patients. In the second layer, the model applies binary classification to detect possible MCI-to-AD progression within three years from a baseline diagnosis. The performance of the model is optimized with key markers selected from a large set of biological and clinical measures. Regarding explainability, we provide, for each layer, global and instance-based explanations of the RF classifier by using the SHapley Additive exPlanations (SHAP) feature attribution framework. In addition, we implement 22 explainers based on decision trees and fuzzy rule-based systems to provide complementary justifications for every RF decision in each layer. Furthermore, these explanations are represented in natural language form to help physicians understand the predictions. The designed model achieves a cross-validation accuracy of 93.95% and an F1-score of 93.94% in the first layer, while it achieves a cross-validation accuracy of 87.08% and an F1-Score of 87.09% in the second layer. The resulting system is not only accurate, but also trustworthy, accountable, and medically applicable, thanks to the provided explanations which are broadly consistent with each other and with the AD medical literature. The proposed system can help to enhance the clinical understanding of AD diagnosis and progression processes by providing detailed insights into the effect of different modalities on the disease risk.

scholarly journals Classification of Sex and Alzheimer’s Disease via Brain Imaging-Based Deep Learning on 85,721 Samples

2020 ◽  
Author(s):  
Bin Lu ◽  
Hui-Xian Li ◽  
Zhi-Kai Chang ◽  
Le Li ◽  
Ning-Xuan Chen ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Deep Learning ◽  
Individual Differences ◽  
Brain Imaging ◽  
Transfer Learning ◽  
Brain Mri ◽  
Classification Model ◽  
Parahippocampal Gyrus ◽  
Industrial Grade

AbstractBeyond detecting brain damage or tumors, little success has been attained on identifying individual differences and brain disorders with magnetic resonance imaging (MRI). Here, we sought to build industrial-grade brain imaging-based classifiers to infer two types of such inter-individual differences: sex and Alzheimer’s disease (AD), using deep learning/transfer learning on big data. We pooled brain structural data from 217 sites/scanners to constitute the largest brain MRI sample to date (85,721 samples from 50,876 participants), and applied a state-of-the-art deep convolutional neural network, Inception-ResNet-V2, to build a sex classifier with high generalizability. In cross-dataset-validation, the sex classification model was able to classify the sex of any participant with brain structural imaging data from any scanner with 94.9% accuracy. We then applied transfer learning based on this model to objectively diagnose AD, achieving 88.4% accuracy in cross-site-validation on the Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset and 91.2% / 86.1% accuracy for a direct test on two unseen independent datasets (AIBL / OASIS). Directly testing this AD classifier on brain images of unseen mild cognitive impairment (MCI) patients, the model correctly predicted 63.2% who eventually converted into AD, versus predicting 22.1% as AD who did not convert into AD during follow-up. Predicted scores of the AD classifier correlated significantly with illness severity. By contrast, the transfer learning framework was unable to achieve practical accuracy for psychiatric disorders. To improve interpretability of the deep learning models, occlusion tests revealed that hypothalamus, superior vermis, thalamus, amygdala and limbic system areas were critical for predicting sex; hippocampus, parahippocampal gyrus, putamen and insula played key roles in predicting AD. Our trained model, code, preprocessed data and an online prediction website have been openly-shared to advance the clinical utility of brain imaging.

scholarly journals Alzheimer's Disease: A Survey

2021 ◽  
Vol 8 (1) ◽  
pp. 33-39
Author(s):  
Harshitha ◽  
Gowthami Chamarajan ◽  
Charishma Y
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Deep Neural Networks ◽  
Brain Area ◽  
Brain Mri ◽  
Three Dimensional ◽  
The Other ◽  
Machine Learning Techniques ◽  
Learning Techniques ◽  
The Brain

Alzheimer's Diseases (AD) is one of the type of dementia. This is one of the harmful disease which can lead to death and yet there is no treatment. There is no current technique which is 100% accurate for the treatment of this disease. In recent years, Neuroimaging combined with machine learning techniques have been used for detection of Alzheimer's disease. Based on our survey we came across many methods like Convolution Neural Network (CNN) where in each brain area is been split into small three dimensional patches which acts as input samples for CNN. The other method used was Deep Neural Networks (DNN) where the brain MRI images are segmented to extract the brain chambers and then features are extracted from the segmented area. There are many such methods which can be used for detection of Alzheimer’s Disease.

scholarly journals A PROPOSED RECOGNITION SYSTEM FOR ALZHEIMER’S DISEASE BASED ON DEEP LEARNING AND OPTIMIZATION ALGORITHMS

2021 ◽  
Vol 56 (5) ◽  
pp. 241-252
Author(s):  
Shereen A. El-Aal ◽  
Neveen I. Ghali
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Deep Learning ◽  
Performance Metrics ◽  
Optimization Algorithms ◽  
Memory Loss ◽  
Recognition System ◽  
Binary Particle Swarm Optimization ◽  
Class Prediction ◽  
Multi Class Classification

Alzheimer's disease (AD) is an advanced and incurable neurodegenerative disease that causes progressive impairment of memory and cognitive functions due to the deterioration of brain cells. Early diagnosis is substantial to avoid permanent memory loss and develop treatments that will be subtracted in the future. Deep learning (DL) is a vital technique for medical imaging systems for AD diagnostics. The problem is multi-class classification seeking high accuracy. DL models have shown strong performance accuracy for multi-class prediction. In this paper, a proposed DL architecture is created to classify magnetic resonance imaging (MRI) to predict different stages of AD-based pre-trained Convolutional Neural Network (CNN) models and optimization algorithms. The proposed model architecture attempts to find the optimal subset of features to improve classification accuracy and reduce classification time. The pre-trained DL models, ResNet-101 and DenseNet-201, are utilized to extract features based on the last layer, and the Rival Genetic algorithm (RGA) and Pbest-Guide Binary Particle Swarm Optimization (PBPSO) are applied to select the optimal features. Then, the DL features and selected features are passed separately through created classifier for classification. The results are compared and analyzed by accuracy, performance metrics, and execution time. Experimental results showed that the most efficient accuracies were obtained by PBPSO selected features which reached 87.3% and 94.8% accuracy with less time of 46.7 sec, 32.7 sec for features based ResNet-101 and DenseNet-201, receptively.

Sign in / Sign up

Export Citation Format

Share Document